March 28, 2019 – Morris Animal Foundation is excited to welcome Dr. Janet Patterson-Kane and Ryan Welch as our new Chief Scientific Officer and Chief Development Officer. Both joined the Foundation in February, and fill roles critical to the Foundation’s continuing growth and success.
“We are thrilled to welcome Janet and Ryan to the Foundation,” said President/ CEO Tiffany Grunert. “Janet is a seasoned leader in veterinary research with a lifelong commitment to animals. She brings a combination of broad-based research experience, organizational knowledge, passion and a demonstrated motivation to advance the Foundation’s mission.
Ryan has a proven track record of securing significant gifts, and skill in designing and implementing successful philanthropic programs. We know he will be an effective leader in our efforts to raise funds to support studies giving animals everywhere longer, healthier lives.”
Dr. Patterson-Kane has more than 25 years of research and clinical experience in the fields of equine, canine, feline and wildlife disease. She was a researcher and professor at the United Kingdom’s Royal Veterinary College, the University of Queensland in Australia, and the University of Glasgow, where she was the first woman to hold the prestigious Chair of Veterinary Pathology.
“As a researcher, I want to make a difference in the lives of animals, and this opportunity continues to make that possible, but on a larger scale,” said Dr. Patterson-Kane. “Morris Animal Foundation is genuinely accelerating the advancement of animal health and I’m proud to take that further.”
Ryan brings 16 years of fundraising and relationship management experience to his new role. He comes to the Foundation from Rocky Mountain Public Media, where he built and maintained relationships with foundations, stakeholders and community partners with excellent levels of retention and loyalty.
“Animals are members of our family and I’ve always had a strong passion for the care and treatment of them,” said Ryan. “l love knowing that, now, my daily work supports the education, research and knowledge to unlock new discoveries and bring revolutionary treatments into practice.”